R&D
🇺🇸 FDA Page 10FDA news and analysis for pharmaceutical BD, investment, and market access · 9 articles on this page
Gain critical insights into global pharmaceutical R&D trends, drug discovery pipelines, and clinical trial advancements. Drive your pharma strategy.
Showing 109–117 of 117 articles
Immunovant Shares Surge on Arthritis Trial Data: What It Means for Pharma
Lilly's Triple-Acting Obesity Drug Achieves Phase 3 Trial Goals
BioMarin's Strategic Move: Voxzogo Label Expansion Insights
Eli Lilly’s Triple-G Drug Achieves Bariatric Surgery-Level Weight Loss
STAT+: Pioneering Trial for Treating Genetic Disease Before Birth
Regeneron Immunotherapy Combo Fails in Melanoma Trial
U.S. Pressure on Germany's Drug Prices: Implications for Pharma
ASCO 2026 Oncology Drug Pipeline Preview
Moderna FDA Talks Focus on Phase 4 COVID Vaccine Data